This 15-minute publication discusses United States Food and Drug Administration (US FDA)-approved biologics used in the treatment of T2-high, uncontrolled asthma and features video-based commentary from an expert faculty member on how biologics have changed the treatment landscape for adults with asthma.
Format
Online Publication
Cost
Complimentary
Credit
0.25 AMA PRA Category 1 Credit™
Patricia Lugar, MD, MS
Associate Professor of Medicine
Chief, Section of Allergy and Immunology
Medical Director, Medication Desensitization Program
Duke Asthma, Allergy and Airway Center
Department of Medicine
Division of Pulmonary, Allergy and Critical Care